Brief: Initiator Pharma Says 43.7% Of Rights Issue Subscribed Through Subscription Rights
July 1 (Reuters) - Initiator Pharma A/S INIT.ST: ANNOUNCES OUTCOME OF RIGHTS ISSUE 43.7% OF RIGHTS ISSUE SUBSCRIBED THROUGH SUBSCRIPTION RIGHTS 2.0% OF RIGHTS ISSUE SUBSCRIBED WITHOUT SUBSCRIPTION RIGHTS 40.4% OF RIGHTS ISSUE SUBSCRIBED THROUGH GUARANTEE UNDERTAKINGS RIGHTS ISSUE TO PROVIDE ABOUT SEK 48.3 MILLION IN PROCEEDS Source text: ID:nMFN4W7FXc Further company coverage: INIT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD